Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Dementia01:30

Dementia

165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
165
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

50
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

27
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
27

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

[Vestibular cortex and vestibular agnosia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Headache in cerebrovascular diseases].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Central sensitization in patients with cerebral small vessel disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Epidemiology and some clinical aspects of primary headaches in children and adolescents].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Alexithymia - traditional and advanced studies].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Chronic traumatic encephalopathy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same journal

[The role of the cerebellum in the coordination of brain activity and the development of autism spectrum disorders].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[A clinical case of anxiety-hypochondriacal depression with extensive somatized symptoms in the elderly].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[De novo variant in the ATP2B2 gene as a cause of neuropsychiatric developmental disorder].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[Electroencephalographic predictors of olfactory stimulus discrimination in COVID-19 survivors].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[Effect of long-term carbamazepine therapy on bone metabolism in women with epilepsy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same journal

[Glial-derived neurotrophic factor and neuropsychological status in COVID-19 survivors].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Sep 9, 2025

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

707

[Demencia cardiogénica]

R G Esin1,2, E A Gorobets1, A I Mashtakova1

  • 1Kazan Federal University, Kazan, Russia.

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|August 29, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Las enfermedades cardíacas contribuyen significativamente a los trastornos cerebrovasculares como el deterioro cognitivo y la demencia. Comprender estos vínculos es crucial para mejorar las estrategias de diagnóstico y prevención.

Palabras clave:
trastornos cognitivosLa demenciainsuficiencia cardíacaEnfermedades del miocardioInfarto de miocardio

Más Videos Relacionados

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.8K
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

1.9K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

707
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.8K
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

1.9K

Área de la Ciencia:

  • Neurología
  • Cardiología
  • Gerontología

Sus antecedentes:

  • Las discusiones sobre enfermedades cerebrovasculares a menudo se centran en las arterias, pasando por alto el papel crítico del corazón.
  • Las afecciones cardíacas son importantes, a menudo dominantes, contribuyentes a los trastornos cerebrovasculares, incluidos el deterioro cognitivo y la demencia.
  • La separación arbitraria de la gestión de las enfermedades cardiovasculares y cerebrovasculares dificulta la atención integral del paciente.

Objetivo del estudio:

  • Revisar la literatura sobre el papel de las enfermedades cardíacas en el deterioro cognitivo y la demencia.
  • Explorar el concepto de "demencia cardiogénica" y sus mecanismos subyacentes.
  • Destacar la importancia de considerar la salud cardíaca en el tratamiento de las enfermedades cerebrovasculares.

Principales métodos:

  • Se llevó a cabo una revisión exhaustiva de la literatura durante un período de 50 años.
  • Las búsquedas se realizaron en las principales bases de datos científicas: eLibrary.ru, CyberLeninka, PubMed, Scopus y Google Scholar.
  • Los términos clave de búsqueda incluyen "infarto de miocardio", "insuficiencia cardíaca", "enfermedad del miocardio", "deterioro cognitivo" y "demencia".

Principales resultados:

  • La evidencia apoya una comprensión más amplia de la patogénesis de la "demencia cardiogénica", un concepto introducido hace casi 50 años.
  • Los mecanismos incluyen hipoperfusión cerebral crónica, inflamación de bajo grado, estrés oxidativo y daño a la barrera hematoencefálica.
  • La renina-angiotensina-aldosterona y la hiperactivación del sistema nervioso simpático están implicadas en la encefalopatía relacionada con la enfermedad del miocardio.

Conclusiones:

  • Las enfermedades cardíacas juegan un papel fundamental en el desarrollo de deterioro cognitivo y demencia.
  • El reconocimiento de la "demencia cardiogénica" requiere enfoques integrados para la atención cardiovascular y neurológica.
  • Una mayor investigación sobre las vías etiológicas compartidas puede mejorar las estrategias de prevención y tratamiento.